News
Adherence to treatment regimens is a significant problem across all of dermatology, and it can be especially pronounced …
Andrew C. Krakowski, MD, FAAD
The FDA has approved Qbrexza™ (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of pr…
FDA Greenlights Restylane Lyft for Hand Rejuvenation
Restylane Lyft is the first hyaluronic acid (HA) injectable gel …
DUPIXENT (dupilumab) performed well in a Phase 3 Trial of inadequately controlled moderate-to-severe atopic dermati…
Kudos to the Skin of Color Society (SOCS) for a banner year.
At its recent annual business meeting held in conjunctio…
Perhaps no surprise to dermatologists, new research reveals that one-third of YouTube videos about atopic dermatitis con…
Newborns emerge from the womb covered with a waxy substance called the vernix, which protects their skin from drying, an…
Aqua Pharmaceuticals, LLC is demonstrating its commitment to the dermatology community by supporting American …
